Structures of influenza A proteins and insights into antiviral drug targets

The world is currently undergoing a pandemic caused by an H1N1 influenza A virus, the so-called 'swine flu'. The H5N1 ('bird flu') influenza A viruses, now circulating in Asia, Africa and Europe, are extremely virulent in humans, although they have not so far acquired the ability to transfer efficiently from human to human. These health concerns have spurred considerable interest in understanding the molecular biology of influenza A viruses. Recent structural studies of influenza A virus proteins (or fragments) help enhance our understanding of the molecular mechanisms of the viral proteins and the effects of drug resistance to improve drug design. The structures of domains of the influenza RNA-dependent RNA polymerase and the nonstructural NS1A protein provide opportunities for targeting these proteins to inhibit viral replication.

[1]  G. Montelione,et al.  Structural basis for suppression of a host antiviral response by influenza A virus , 2008, Proceedings of the National Academy of Sciences.

[2]  Joe D. Lewis,et al.  The structural basis for cap binding by influenza virus polymerase subunit PB2 , 2008, Nature Structural &Molecular Biology.

[3]  Gerardo Chowell,et al.  Severe respiratory disease concurrent with the circulation of H1N1 influenza. , 2009, The New England journal of medicine.

[4]  J. Chou,et al.  Mechanism of drug inhibition and drug resistance of influenza A M2 channel , 2009, Proceedings of the National Academy of Sciences.

[5]  E. Kuechler,et al.  Identification of the cap binding protein of influenza virus. , 1982, Nucleic acids research.

[6]  W G Laver,et al.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.

[7]  J. N. Varghese,et al.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution , 1983, Nature.

[8]  H. Takeuchi,et al.  Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza a virus. , 2001, Biochemistry.

[9]  R. Krug,et al.  Interaction of the Influenza A Virus Nucleocapsid Protein with the Viral RNA Polymerase Potentiates Unprimed Viral RNA Replication , 2008, Journal of Virology.

[10]  David J. Stevens,et al.  The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design , 2006, Nature.

[11]  B. Prasad,et al.  X-ray structure of influenza virus NS1 effector domain , 2006, Nature Structural &Molecular Biology.

[12]  Yoshihiro Kawaoka,et al.  Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses , 2010, PLoS pathogens.

[13]  B. G. Hale,et al.  Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein , 2010, Proceedings of the National Academy of Sciences.

[14]  F A Quiocho,et al.  Structural basis for sequence-nonspecific recognition of 5'-capped mRNA by a cap-modifying enzyme. , 1998, Molecular cell.

[15]  B. Prasad,et al.  X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus , 2008, Nature.

[16]  T. Chung,et al.  Recombinant influenza virus polymerase: requirement of both 5' and 3' viral ends for endonuclease activity , 1994, Journal of virology.

[17]  Richard E. Randall,et al.  Influenza A virus NS1 protein binds p85β and activates phosphatidylinositol-3-kinase signaling , 2006, Proceedings of the National Academy of Sciences.

[18]  Helena J. Maier,et al.  Differential role of the influenza A virus polymerase PA subunit for vRNA and cRNA promoter binding. , 2008, Virology.

[19]  J. Skehel,et al.  Structure of influenza haemagglutinin at the pH of membrane fusion , 1994, Nature.

[20]  G. Kochs,et al.  Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein , 2007, Journal of Virology.

[21]  R. Webster,et al.  Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants. , 2006, Antiviral research.

[22]  W. DeGrado,et al.  Discovery of spiro-piperidine inhibitors and their modulation of the dynamics of the M2 proton channel from influenza A virus. , 2009, Journal of the American Chemical Society.

[23]  Cinque S. Soto,et al.  Structure of the Amantadine Binding Site of Influenza M2 Proton Channels In Lipid Bilayers , 2010, Nature.

[24]  Sek-Man Wong,et al.  Structural basis for dsRNA recognition by NS1 protein of influenza A virus , 2009, Cell Research.

[25]  Yoshihiro Kawaoka,et al.  T-705 (favipiravir) activity against lethal H5N1 influenza A viruses , 2009, Proceedings of the National Academy of Sciences.

[26]  R. Bertram,et al.  Backbone structure of the amantadine-blocked trans-membrane domain M2 proton channel from Influenza A virus. , 2007, Biophysical journal.

[27]  T. Steitz,et al.  Structural basis for the 3′‐5′ exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. , 1991, The EMBO journal.

[28]  José L Carrascosa,et al.  3D structure of the influenza virus polymerase complex: Localization of subunit domains , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Taubenberger,et al.  The 1918 Spanish influenza: integrating history and biology. , 2001, Microbes and infection.

[30]  The Structural Basis for an Essential Subunit Interaction in Influenza Virus RNA Polymerase , 2008 .

[31]  R. Stevens,et al.  Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Antiinfluenza Activity. , 1997 .

[32]  N. Daigle,et al.  Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit , 2007, Nature Structural &Molecular Biology.

[33]  R. Krug,et al.  Influenza A Virus Polymerase Is an Integral Component of the CPSF30-NS1A Protein Complex in Infected Cells , 2008, Journal of Virology.

[34]  S. Cusack,et al.  Three-dimensional model for the isolated recombinant influenza virus polymerase heterotrimer , 2007, Nucleic acids research.

[35]  R. Krug,et al.  The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA , 2006, Nature.

[36]  A. Gingras,et al.  Cocrystal Structure of the Messenger RNA 5′ Cap-Binding Protein (eIF4E) Bound to 7-methyl-GDP , 1997, Cell.

[37]  Gira Bhabha,et al.  Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.

[38]  Zihe Rao,et al.  Crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site , 2009, Nature.

[39]  R. Lamb,et al.  Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue. , 1995, Biophysical journal.

[40]  S. Harrison.  Viral membrane fusion , 2008, Nature Structural &Molecular Biology.

[41]  A. Joachimiak,et al.  Crystal structure of the polymerase PAC–PB1N complex from an avian influenza H5N1 virus , 2008, Nature.

[42]  Jonathan W. Yewdell,et al.  A novel influenza A virus mitochondrial protein that induces cell death , 2001, Nature Medicine.

[43]  Vikas Nanda,et al.  Structural basis for the function and inhibition of an influenza virus proton channel , 2008, Nature.

[44]  Pang-Chui Shaw,et al.  Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  G. Neumann,et al.  Influenza A virus NS2 protein mediates vRNP nuclear export through NES‐independent interaction with hCRM1 , 2000, The EMBO journal.

[46]  J. Sebolt-Leopold,et al.  Mechanisms of drug inhibition of signalling molecules , 2006, Nature.

[47]  D. Hazuda,et al.  Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds , 1994, Antimicrobial Agents and Chemotherapy.

[48]  D. Obrecht,et al.  Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors. , 2003, Journal of medicinal chemistry.

[49]  J. Carrascosa,et al.  The Structure of a Biologically Active Influenza Virus Ribonucleoprotein Complex , 2009, PLoS pathogens.

[50]  R. Krug,et al.  Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Xianghong Jing,et al.  Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel , 2008, Proceedings of the National Academy of Sciences.

[52]  S. Cady,et al.  Structure of amantadine-bound M2 transmembrane peptide of influenza A in lipid bilayers from magic-angle-spinning solid-state NMR: the role of Ser31 in amantadine binding. , 2009, Journal of molecular biology.

[53]  J. N. Varghese,et al.  Structure of the catalytic and antigenic sites in influenza virus neuraminidase , 1983, Nature.

[54]  P. Digard,et al.  The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. , 2002, The Journal of general virology.

[55]  R. Krug,et al.  The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Ronald Frank,et al.  Peptide-Mediated Interference with Influenza A Virus Polymerase , 2007, Journal of Virology.

[57]  Michael K Gilson,et al.  Evaluation of the substrate envelope hypothesis for inhibitors of HIV‐1 protease , 2007, Proteins.

[58]  Subrata Barman,et al.  Assembly and budding of influenza virus , 2004, Virus Research.

[59]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[60]  S. de la Luna,et al.  The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis , 1996, Journal of virology.

[61]  N. Pante,et al.  The directionality of the nuclear transport of the influenza A genome is driven by selective exposure of nuclear localization sequences on nucleoprotein , 2009, Virology Journal.

[62]  G. Montelione,et al.  A novel RNA-binding motif in influenza A virus non-structural protein 1 , 1997, Nature Structural Biology.

[63]  Ron A M Fouchier,et al.  Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.

[64]  Helen M. Berman,et al.  Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein , 1997, Nature Structural Biology.

[65]  A. Moscona,et al.  Oseltamivir resistance--disabling our influenza defenses. , 2005, The New England journal of medicine.

[66]  R. Lamb,et al.  The Gate of the Influenza Virus M2 Proton Channel Is Formed by a Single Tryptophan Residue* , 2002, The Journal of Biological Chemistry.

[67]  David J Stevens,et al.  Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion , 2008, Proceedings of the National Academy of Sciences.

[68]  E. Obayashi,et al.  Structural insight into the essential PB1–PB2 subunit contact of the influenza virus RNA polymerase , 2009, The EMBO journal.

[69]  Rei-Lin Kuo,et al.  The CPSF30 Binding Site on the NS1A Protein of Influenza A Virus Is a Potential Antiviral Target , 2006, Journal of Virology.

[70]  Jeffery K. Taubenberger,et al.  Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.

[71]  Mark von Itzstein,et al.  The war against influenza: discovery and development of sialidase inhibitors. , 2007, Nature reviews. Drug discovery.

[72]  Mark von Itzstein,et al.  The war against influenza: discovery and development of sialidase inhibitors , 2007, Nature Reviews Drug Discovery.

[73]  J. Chou,et al.  Structure and mechanism of the M2 proton channel of influenza A virus , 2008, Nature.

[74]  R. Lamb,et al.  Orthomyxoviridae: The Viruses and Their Replication. , 1996 .

[75]  N. Meanwell,et al.  Structure-activity relationships for a series of thiobenzamide influenza fusion inhibitors derived from 1,3,3-trimethyl-5-hydroxy-cyclohexylmethylamine. , 2002, Bioorganic & medicinal chemistry letters.

[76]  S. Cusack,et al.  Host Determinant Residue Lysine 627 Lies on the Surface of a Discrete, Folded Domain of Influenza Virus Polymerase PB2 Subunit , 2008, PLoS pathogens.

[77]  H. Tsuge,et al.  Structural Basis of the Influenza A Virus RNA Polymerase PB2 RNA-binding Domain Containing the Pathogenicity-determinant Lysine 627 Residue* , 2009, Journal of Biological Chemistry.

[78]  Stephen H Hughes,et al.  Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors. , 2005, Progress in biophysics and molecular biology.

[79]  R. Lamb,et al.  The M2 Proton Channels of Influenza A and B Viruses* , 2006, Journal of Biological Chemistry.

[80]  A. Iguchi,et al.  Influenza virus inhibits cleavage of the HSP70 pre-mRNAs at the polyadenylation site. , 1999, Virology.

[81]  R. Krug,et al.  A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription , 1981, Cell.

[82]  R. Krug,et al.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. , 1998, Molecular cell.

[83]  R. Krug,et al.  A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. , 2007, Virology.

[84]  Boguslaw Stec,et al.  Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses , 2009, Nature Structural &Molecular Biology.

[85]  Andrew A. McCarthy,et al.  The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit , 2009, Nature.

[86]  P. Colman.  New antivirals and drug resistance. , 2009, Annual review of biochemistry.

[87]  S. Harrison,et al.  RNA Synthesis in a Cage—Structural Studies of Reovirus Polymerase λ3 , 2002, Cell.

[88]  Wenbin Luo,et al.  Structure and function of the influenza A M2 proton channel. , 2009, Biochemistry.

[89]  I. Wilson,et al.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution , 1981, Nature.

[90]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[91]  Alan J. Hay,et al.  Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants , 2008, Nature.

[92]  Bostjan Kobe,et al.  Structural Basis for the Specificity of Bipartite Nuclear Localization Sequence Binding by Importin-α* , 2003, Journal of Biological Chemistry.

[93]  A. Shatkin.  Viruses with segmented ribonucleic acid genomes: multiplication of influenza versus reovirus. , 1971, Bacteriological reviews.